The Cardiac Valve Designed By Turkish Scientist
The "cardiac valve" model designed by Karadeniz Technical University (KTÜ) Medical School Instructor Prof. Dr. Ömer Gedikli has been registered with national patent.
The Cardiac Valve Designed By Turkish Scientist
The "cardiac valve" model designed by Karadeniz Technical University (KTÜ) Medical School Instructor Prof. Dr. Ömer Gedikli has been registered with national patent. In the statement he has published, Prof. Dr. Gedikli emphasized that surgical replacement of valves is not possible due to risks posed by advanced age or comorbidities and that the replacement of mitral valve using catheters by vascular means - without the need for open surgery - is an issue awaiting solution in patient groups. Pointing out to the fact that transcatheter mitral valve replacement has been experimented in other studies using numerous different designs, Gedikli stated that his design aims to coming up with a solution for the issues faced in transcatheter mitral valve replacement which makes treatment possible for inoperable mitral valve patients. Gedikli emphasized that surgical replacement of valves is not possible in about half of the patients due to risks posed by advanced age or comorbidities and that the replacement of mitral valve using catheters by vascular means - without the need for open surgery - is an issue awaiting solution in this group of patients.
Gedikli underlined that the biggest issue to be overcome by transcatheter valves is to hold on to the anatomic structures around the valve and maintain the stabile position during cardiac movements, and then he continued as follows:
"Therefore the attachments with which these valves hold on to the surrounding bodies have the greatest significance in the design. In this model I have designed, the two different parts on the valve hold on to the interatrial septum and the left atrial appendix, keeping the valve in stabile position during cardiac movements. Also these attachments are easy to implant, with no possibility of pressing on the other cardiac tissues."
The statement purports that the "cardiac valve" model designed by Gedikli has been registered with national patent and goes on to say, "Once these valve models have been proven to be effective first in animal studies and then in human studies, treating the inoperable mitral valve patients will become possible."
Gedikli underlined that the biggest issue to be overcome by transcatheter valves is to hold on to the anatomic structures around the valve and maintain the stabile position during cardiac movements, and then he continued as follows:
"Therefore the attachments with which these valves hold on to the surrounding bodies have the greatest significance in the design. In this model I have designed, the two different parts on the valve hold on to the interatrial septum and the left atrial appendix, keeping the valve in stabile position during cardiac movements. Also these attachments are easy to implant, with no possibility of pressing on the other cardiac tissues."
The statement purports that the "cardiac valve" model designed by Gedikli has been registered with national patent and goes on to say, "Once these valve models have been proven to be effective first in animal studies and then in human studies, treating the inoperable mitral valve patients will become possible."